Teewinot Capital Advisers, L.L.C. Novo Nordisk A S Transaction History
Teewinot Capital Advisers, L.L.C.
- $940 Million
- Q1 2025
A detailed history of Teewinot Capital Advisers, L.L.C. transactions in Novo Nordisk A S stock. As of the latest transaction made, Teewinot Capital Advisers, L.L.C. holds 36,497 shares of NVO stock, worth $2.9 Million. This represents 0.27% of its overall portfolio holdings.
Number of Shares
36,497
Previous 36,497
-0.0%
Holding current value
$2.9 Million
Previous $3.14 Million
19.27%
% of portfolio
0.27%
Previous 0.32%
Shares
1 transactions
Others Institutions Holding NVO
# of Institutions
1,769Shares Held
330MCall Options Held
11.3MPut Options Held
15.5M-
Jennison Associates LLC18.8MShares$1.49 Billion0.93% of portfolio
-
Bank Of America Corp Charlotte, NC14.8MShares$1.17 Billion0.08% of portfolio
-
Loomis Sayles & CO L P12.4MShares$983 Million1.24% of portfolio
-
Morgan Stanley New York, NY12.3MShares$977 Million0.06% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa11.9MShares$942 Million0.36% of portfolio
About NOVO NORDISK A S
- Ticker NVO
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 2,257,289,984
- Market Cap $179B
- Description
- Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...